| Literature DB >> 30823922 |
Laura Esquius1,2, Sergi Garcia-Retortillo3,4, Natàlia Balagué5, Robert Hristovski6, Casimiro Javierre2.
Abstract
BACKGROUND: The consumption of olive oil is associated with a diminished risk of cardiovascular disorders and mortality, but the impact of olive oil supplementation on endurance performance is still unclear. Since the beneficial effects of olive oil are observed at a systemic level, its effectiveness may not be precisely measured through the commonly registered maximal and threshold values of some physiological and performance parameters. In contrast, we suggest evaluating it through variables able to capture the coordinated behaviour of physiological systems. Thus, the aim of the current research was to assess the effect of an acute extra virgin olive oil supplementation on cardiorespiratory coordination (CRC) and performance, compared to palm oil.Entities:
Keywords: Cardiorespiratory coordination; Cardiorespiratory exercise testing; Complex adaptive systems; Dietary supplementation; Olive oil; Polyphenols; Principal components analysis; Unsaturated fatty acids
Mesh:
Substances:
Year: 2019 PMID: 30823922 PMCID: PMC6397506 DOI: 10.1186/s12970-019-0279-6
Source DB: PubMed Journal: J Int Soc Sports Nutr ISSN: 1550-2783 Impact factor: 5.150
Supplement ingredients and nutritional content
| Active A | Active B | Placebo | |
|---|---|---|---|
| Ingredients | 100 ml orange juice | 100 ml orange juice | 100 ml orange juice |
| 25 ml Extra-virgin olive oil | 25 ml Palm oil | 8 g Modified starch | |
| 8 g Modified starch | 8 g Modified starch | ||
| Energy (Kcal) | 277 | 277 | 52.8 |
| Lipids (g) | 25 | 25 | 0.1 |
| Carbohydrates (g) | 12.6 | 12.6 | 12.6 |
Means (standard deviations) of PC1 eigenvalues and projection of the selected cardiorespiratory variables onto PC1
| 1st third | 2nd third | 3rd third | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Olive Oil | Palm Oil | Placebo | Olive Oil | Palm Oil | Placebo | Olive Oil | Palm Oil | Placebo | |
| PC1 Eigenvalues | 2,47 | 2,43 | 2,53 | 2,63a | 2,30a | 2,38a | 2,48 | 2,42 | 2,59 |
| (0,42) | (0,58) | (0,26) | (0,51) | (0,28) | (0,36) | (0,39) | (0,32) | (0,21) | |
| Veprojection | 0,86 | 0,82 | 0,84 | 0,91a | 0,79a | 0,89a | 0,83 | 0,92 | 0,96 |
| (0,06) | (0,13) | (0,07) | (0,03) | (0,17) | (0,05) | (0,34) | (0,06) | (0,02) | |
| FeO2projection | 0,57 | 0,67 | 0,58 | 0,61 | 0,64 | 0,50 | 0,71 | 0,78 | 0,83 |
| (0,29) | (0,23) | (0,20) | (0,20) | (0,30) | (0,28) | (0,31) | (0,26) | (0,17) | |
| FeCO2projection | 0,70 | 0,86 | 0,79 | 0,66 | 0,73 | 0,63 | 0,55 | 0,51 | 0,42 |
| (0,66) | (0,13) | (0,31) | (0,34) | (0,17) | (0,28) | (0,18) | (0,31) | (0,26) | |
| HRprojection | 0,76 | 0,58 | 0,86 | 0,92 | 0,75 | 0,87 | 0,82 | 0,69 | 0,84 |
| (0,07) | (0,62) | (0,32) | (0,03) | (0,20) | (0,14) | (0,21) | (0,30) | (0,15) | |
a, statistically significant differences among dietary supplementations; PC principal component, VE ventilation, FeO2 expired fraction of oxygen, FeCO2 expired fraction of carbon dioxide, HR heart rate
Means (standard deviations) of performance and physiological variables, under olive oil, palm oil, and placebo supplementations
| Variables | Values | Olive oil | Palm oil | Placebo | Statistical differences |
|---|---|---|---|---|---|
| Exercising time (min) | Maximal | 77.3 (2.0) | 76.3 (2.3) | 77.4 (2.3) | |
| Respiratory rate (b·min− 1) | AT | 31.6 (1.1) | 31.4 (1.8) | 32.7 (1.6) | |
| AnT | 37.5 (3.1) | 41.2 (4.1) | 39.2 (2.5) | ||
| Maximal | 46.5 (4.1) | 52.3 (7.6) | 48.7 (5.1) | ||
| Ventilation (L·min−1) | AT | 53.3 (4.6) | 58.7 (4.7) | 57.4 (5.5) | (1) |
| AnT | 83.9 (8.3) | 87.7 (10.5) | 90.5 (8.7) | ||
| Maximal | 112.9 (9.1) | 119.8 (16.5) | 117.9 (11.7) | ||
| Oxygen uptake (L·min−1) | AT | 2.15 (0.16) | 2.31 (0.20) | 2.36 (0.24) | |
| AnT | 3.19 (0.2) | 3.22 (0.3) | 3.40 (0.2) | ||
| Peak | 3.85 (0.1) | 3.96 (0.2) | 4.00 (0.2) | ||
| PETO2 (mmHg) | AT | 100.9 (1.3) | 102.7 (1.3) | 102.3 (1.2) | (1) |
| AnT | 103.8 (2.2) | 105.3 (2.7) | 104.2 (1.9) | ||
| Maximal | 108.6 (2.7) | 109.6 (3.5) | 108.8 (2.8) | ||
| PETCO2 (mmHg) | AT | 42.1 (0.9) | 40.1 (0.8) | 40.9 (0.9) | (2) |
| AnT | 41.7 (3.7) | 39.7 (3.8) | 41.2 (3.6) | ||
| Maximal | 38.8 (1.7) | 37.6 (2.3) | 39.4 (1.6) | ||
| FeO2 (%) | AT | 16.2 (0.1) | 16.4 (0.1) | 16.2 (0.1) | |
| AnT | 16.4 (0.2) | 16.5 (0.3) | 16.4 (0.2) | ||
| Maximal | 16.8 (0.3) | 16.8 (0.3) | 16.8 (0.3) | ||
| FeCO2 (%) | AT | 4.3 (0.1) | 4.1 (0.1) | 4.3 (0.1) | |
| AnT | 4.4 (0.1) | 4.2 (0.2) | 4.3 (0.2) | ||
| Maximal | 4.1 (0.2) | 4.1 (0.2) | 4.3 (0.2) |
AT aerobic threshold (moderate exercise intensity), AnT anaerobic threshold (high exercise intensity), PETO, end-tidal partial pressure of oxygen, PETCO end-tidal partial pressure of carbon dioxide, FeO expired fraction of O2, FeCO expired fraction of CO2, (1), statistically significant differences between olive oil and palm oil; (2), statistically significant differences between olive oil and placebo
Fig. 1Representation of the selected physiological variables in one single participant during the three dietary supplementations (olive oil, palm oil, and placebo). Each test was divided into three equal sections (low, moderate, and high intensity). The vertical red doted lines indicate the occurrence of aerobic and anaerobic thresholds. Note that a reduction in VE was observed at moderate intensity under olive oil supplementation. AT, aerobic threshold; AnT, anaerobic threshold